CYRX

CryoPort (CYRX)

About CryoPort (CYRX)

CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Brentwood, TN.

Details

Daily high
$8.10
Daily low
$7.49
Price at open
$7.49
52 Week High
$20.10
52 Week Low
$5.32
Market cap
388.5M
Dividend yield
0.00%
Volume
496,954
Avg. volume
448,846
P/E ratio
-2.32

CryoPort News

Details

Daily high
$8.10
Daily low
$7.49
Price at open
$7.49
52 Week High
$20.10
52 Week Low
$5.32
Market cap
388.5M
Dividend yield
0.00%
Volume
496,954
Avg. volume
448,846
P/E ratio
-2.32